The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 1993;328(15):1136.

Original Article
PreviousPrevious
Volume 328:10-14 January 7, 1993 Number 1
NextNext

Association between Polymorphism of the Glycogen Synthase Gene and Non-Insulin-Dependent Diabetes Mellitus
Leif C. Groop, Maija Kankuri, Camilla Schalin-Jantti, Agneta Ekstrand, Pirjo Nikula-Ijas, Elisabeth Widen, Esa Kuismanen, Johan Eriksson, Anja Franssila-Kallunki, Carola Saloranta, and Saija Koskimies

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
ABSTRACT

Background The storage of glucose as glycogen in skeletal muscle is frequently impaired in patients with non-insulin-dependent diabetes mellitus (NIDDM) and their nondiabetic relatives. Despite an intensive search for candidate genes associated with NIDDM, no data have been available on the gene coding for the key enzyme of this pathway, glycogen synthase.

Methods and Results Using a human complementary DNA probe, the restriction enzyme XbaI, and Southern blot analysis, we identified two polymorphic alleles, A1 and A2, in the glycogen synthase gene. The gene was localized to chromosome 19. The A1A2 or A2A2 genotype was found in 30 percent of 107 patients with NIDDM but in only 8 percent of 164 nondiabetic subjects without a family history of NIDDM (P<0.001). The diabetic patients with the A2 allele had a stronger family history of NIDDM (P = 0.019), a higher prevalence of hypertension (P = 0.008), and a more severe defect in insulin-stimulated glucose storage (P = 0.001) than the diabetic patients with the A1 allele. The concentration of the glycogen synthase protein in biopsy specimens of skeletal muscle from the patients with the A2 allele was normal, however, suggesting that expression of the gene was unaltered. The XbaI polymorphism was due to a change of a single base in an intron.

Conclusions The XbaI polymorphism of the glycogen synthase gene identifies a subgroup of patients with NIDDM characterized by a strong family history of NIDDM, a high prevalence of hypertension, and marked insulin resistance.


Source Information

From the Fourth Department of Medicine (L.C.G., C.S.-J., A.E., E.W., J.E., A.F.-K., C.S.) and the Department of Biochemistry (M.K., P.N.-I., E.K.), Helsinki University, and the Finnish Red Cross Blood Transfusion Service (S.K.), both in Helsinki, Finland.

Address reprint requests to Dr. Groop at the Fourth Department of Medicine, Helsinki University Hospital, Unioninkatu 38, SF-00170 Helsinki, Finland.

Full Text of this Article


Related Letters:

Polymorphism of the Glycogen Synthase Gene and Non-Insulin-Dependent Diabetes Mellitus
Zouali H., Velho G., Froguel P., Kadowaki T., Kadowaki H., Yazaki Y., Groop L., Schalin-Jantti C., Lehto M.
Extract | Full Text  
N Engl J Med 1993; 328:1568-1569, May 27, 1993. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.